Japan has approved the world's first stem cell therapy for Parkinson's disease, offering new hope for millions globally. The treatment uses Induced Pluripotent Stem Cells (iPSCs) to replace damaged dopamine-producing neurons in the brain. Expected to reach patients soon, experts say the breakthrough could transform Parkinson's treatment and advance regenerative medicine on a worldwide scale.